Univo Pharmaceuticals Ltd Stock TEL AVIV STOCK EXCHANGE
Equities
UNVO
IL0010935588
Biotechnology & Medical Research
Sales 2019 | 0.82 3.11 1.13 | Sales 2020 | 33.68 126.93 46.02 | Capitalization | 75.1M 283M 103M |
---|---|---|---|---|---|
Net income 2019 | -11M -41.46M -15.03M | Net income 2020 | - 0 0 | EV / Sales 2019 | 35,543,010 x |
Net cash position 2019 | 22.82M 86M 31.18M | Net Debt 2020 | 4.12M 15.53M 5.63M | EV / Sales 2020 | 2,352,105 x |
P/E ratio 2019 * |
-
| P/E ratio 2020 |
-
| Employees | - |
Yield 2019 * |
-
| Yield 2020 |
-
| Free-Float | 59.28% |
Managers | Title | Age | Since |
---|---|---|---|
Golan Bitton
CEO | Chief Executive Officer | 47 | 93-04-03 |
Jonathan Eilat
IRC | Investor Relations Contact | - | - |
Noam Frakash
AUD | Comptroller/Controller/Auditor | 41 | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chaim Hurvitz
CHM | Chairman | 63 | 19-07-14 |
Golan Bitton
CEO | Chief Executive Officer | 47 | 93-04-03 |
1st Jan change | Capi. | |
---|---|---|
+2.36% | 42.75B | |
+47.75% | 41.61B | |
+12.37% | 41.34B | |
-12.36% | 26.59B | |
+8.51% | 25.49B | |
-23.43% | 18.12B | |
+30.52% | 12.24B | |
-1.77% | 11.76B | |
+8.40% | 11B |